Philadelphia, PA, United States of America

Julia Leu

This inventor holds 1 USPTO granted patent. Top assignees: The Wistar Institute, University of Pennsylvania. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julia Leu. Retrieved from https://idiyas.com/inventor/julia-leu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Julia Leu: Innovator in Cancer Treatment

Introduction

Julia Leu is a prominent inventor based in Philadelphia, PA, who has made significant contributions to the field of cancer treatment. With a focus on innovative therapies, she has developed a patent that addresses critical challenges in oncology, particularly colorectal cancer.

Latest Patents

Julia Leu holds a patent for "HSP70 inhibitors and methods of using same." This patent discloses compounds and compositions that can be utilized to treat, ameliorate, and prevent cancer, especially colorectal cancer (CRC). The compounds described in her patent inhibit HSP70, promote immune cell recruitment to cancer sites, and enhance immune cell infiltration in tumors. This innovative approach has the potential to improve treatment outcomes for patients suffering from cancer.

Career Highlights

Throughout her career, Julia has worked with esteemed institutions such as The Wistar Institute and the University of Pennsylvania. Her experience in these research environments has allowed her to develop groundbreaking therapies and contribute to the advancement of cancer research.

Collaborations

Due to space constraints, the details of her collaborations will not be included.

Conclusion

Julia Leu's work in developing HSP70 inhibitors represents a significant advancement in cancer treatment. Her innovative approach and dedication to research continue to inspire progress in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…